Handelsavisen
prelaunch
Companies ›Healthcare ›ALKLH.PA
AL
ALKLH.PA — Euronext Paris Healthcare Facilities & Services

Alklh.Pa

€0,16
Open in Charts → Attach watcher ⌖
— —
EUR
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
16,3 %
ROE
8,3 %
Net margin
10,3 %
Debt / equity
0,19
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

ALKLH.PA operates in the biotechnology sector, focusing on healthcare facilities and services, and generates revenue primarily through its operations in health care equipment and supplies.

Business. ALKLH.PA operates in the biotechnology sector, focusing on healthcare facilities and services, and generates revenue primarily through its operations in health care equipment and supplies.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
8,3 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ALKLH.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ALKLH.PA. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    ALKLH.PA operates in the biotechnology sector, focusing on healthcare facilities and services, and generates revenue primarily through its operations in health care equipment and supplies.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    ALKLH.PA maintains a conservative capital structure with a debt-to-equity ratio of 0.19, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 0.99, suggesting that it has nearly equal current assets to current liabilities. The company's free cash flow of 2,774,000 EUR indicates a positive cash flow from operations after capital expenditures.

    In terms of profitability, ALKLH.PA reports a return on equity of 8.26% and a return on assets of 6.12%, which are metrics that reflect the company's efficiency in generating profits from its equity and total assets, respectively. These figures should be compared against the industry median to determine if the company is outperforming or underperforming its peers.

    The company's revenue is concentrated within the healthcare services and equipment industry, with no disclosed geographic diversification provided in the available data. This concentration may expose the company to specific market risks associated with the healthcare sector.

    ALKLH.PA's growth trajectory is not explicitly detailed in the provided data, but the company's operating income of 3,622,000 EUR and net income of 2,281,000 EUR suggest a profitable operation. The outlook for the company's revenue and earnings would depend on the performance of the healthcare sector and the company's ability to maintain or grow its market share.

    The risk assessment for ALKLH.PA indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could affect its ability to meet short-term obligations without additional financing. The dilution risk is low, suggesting that the company is not expected to issue a significant number of new shares in the near future.

    Recent events related to ALKLH.PA are not detailed in the provided data, but the company's financial performance and risk profile should be monitored for any changes that could impact its valuation and operational stability.

    Key takeaways
    • ALKLH.PA has a low debt-to-equity ratio, indicating a conservative capital structure.
    • The company's return on equity and return on assets are positive, suggesting efficient use of capital.
    • The company's liquidity position is medium, with a current ratio close to 1.
    • The company's revenue is concentrated in the healthcare services and equipment industry.
    • The risk assessment indicates a medium liquidity risk and a low dilution risk.
    • margin_outlook_rationale: The company's gross profit margin is high, indicating strong cost control and pricing power.
    • rd_outlook_rationale: No specific information is provided regarding the company's research and development activities.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    €0,16
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    €27.6M
    Net cashⓘ
    -€5.2M
    Current ratioⓘ
    1.0
    Debt / equityⓘ
    0.2
    ROAⓘ
    6.1%
    ROEⓘ
    8.3%
    Cash conversionⓘ
    216.0%
    CapEx / revenueⓘ
    -4.6%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin16,3 %Above P75
    Net Margin10,3 %Above median
    ROE8,3 %Above median
    Capex / Rev-4,6 %Above median
    D/E0,19Above median
    Cash Conv2,16Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • ALKLH.PA Market data — financials · 2026-05-27
    • Klea Holding SA Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ALKLH.PACanonical
    Euronext Paris · EUR

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage